Newsfile Corp
29 Sept 2026, 07:30 UTC · 45m ago
Verdict
Headline takes no side. We score TELO +0.80 across two claims — strongly bullish.
+0.80strongly bullish
More positive than 88% of ticker scores this week
What the story claims
2 claims · scored −1 bearish … +1 bullish · 1 new · 1 priced in
In a comparison with Adaptive clonoSEQ, blood-based TELO enumeration identified circulating plasma cells in 100% of evaluable specimens, including all Adaptive-positive samples and those non-evaluable by NGS.
Newreported today, September 29, 2026
So whatThe ability to track the 2 patients non-evaluable by NGS expands the addressable patient population for their MRD tool.
More positive than 93% of claims this week
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
TELO-MRD detected circulating myeloma cells in 92.9% (39/42) of samples compared to 54.8% (23/42) detected by bone-marrow EuroFlow NGF in a previous head-to-head analysis.
Priced intext states the company previously reported this
So whatThis 38.1% delta in detection rate provides the clinical baseline for the newer Adaptive clonoSEQ data reported today.
More positive than 79% of claims this week
Which stocks this story touches
More positive than 88% of ticker scores this week
The company reported positive clinical research results showing its TELO-MRD program may be more sensitive than existing bone-marrow based tests.
More negative than 62% of ticker scores this week
The article highlights limitations of the clonoSEQ assay, specifically its reliance on bone marrow and requirement for a dominant clone, compared to Telo's method.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
The Motley Fool
5h ago
—
TELO hasn't traded since this ran. Last close $1.20 (Sep 28); the reaction starts at the next open.
TELO chart →
